Scientific research is continually evolving, and new technologies are enabling faster, more accurate, and cruelty-free testing. One of the most promising developments is the use of microfluidic devices in laboratory testing. These devices help create controlled environments that mimic human situations, making them valuable for pharmaceutical, beauty, and medical research.
Medelink specializes in skin roughness measuring system, offering advanced technology for precise skin texture analysis. Their innovative devices use high-resolution imaging and AI-driven diagnostics to assess skin roughness, fine lines, and surface irregularities. Designed for dermatologists, skincare professionals, and cosmetic researchers, Medelink’s system provides accurate data for personalized skincare, product development, and clinical research. By delivering detailed insights into skin health, Medelink helps professionals enhance treatment effectiveness and product formulation. With a commitment to innovation and precision, Medelink empowers the beauty and healthcare industries with cutting-edge skin analysis solutions.
Medelink is a pioneering company specializing in Organ on Chip technology, revolutionizing biomedical research and drug development. By replicating human organ functions on microfluidic chips, Medelink provides cutting-edge solutions for drug testing, disease modeling, and personalized medicine. Their advanced technology enhances research accuracy, reduces reliance on animal testing, and accelerates medical breakthroughs. With a commitment to innovation and precision, Medelink empowers scientists and pharmaceutical companies to develop safer, more effective treatments.
Medelink’s Relego 4D Organ-on-Chip technology offers an advanced microfluidic environment for studying organ-level responses. This technology enhances drug testing, toxicology, and personalized medicine by mimicking human physiology with high precision. Ideal for researchers, it accelerates breakthroughs in pharmaceuticals, dermatology, and regenerative medicine, reducing reliance on animal testing.
